Attorney General Jonathan Skrmetti reminds Tennesseans of their right to delete genetic data amid 23AndMe bankruptcy filing
NASHVILLE, Tenn. (WKRN) — The message from Tennessee Attorney General Jonathan Skrmetti is that you have a right to delete your genetic testing results from 23andMe's database.
The genetic testing company has filed for bankruptcy. In a Friday press release, Skrmetti's office said that 23andMe intends to substantially sell its assets as part of the bankruptcy process. Those assets, Skrmetti's office said, include personal data and genetic testing results from customers.
RELATED: Consider deleting your 23andMe data now, California AG urges
'Our genetic information is some of our most personal data, giving insight about not just us but our families,' Skrmetti said. 'People trusted 23andMe with their DNA to learn more about who they are, and now the company appears poised to sell that incredibly sensitive data to unknown buyers. Any Tennessee consumer who wants to delete their data and ensure their sample is destroyed should follow the step-by-step instructions provided on our website.'
In July 2023, the state's Genetic Information Privacy Act went into effect. That law requires companies to protect consumers' private information and provide consumers with the ability to access their data and destroy their biological sample, if they want.
⏩
If you're a 23andMe customer in Tennessee and you want to learn more about how to download a copy of your genetic data and delete it, follow this link.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
27 minutes ago
- Los Angeles Times
States sue to block the sale of genetic data collected by DNA testing company 23andMe
Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company's sale of its customers' genetic data without explicit consent. The suit, filed this week in U.S. Bankruptcy Court in the Eastern District of Missouri, comes months after 23andMe began a court-supervised sale process of its assets. The South San Francisco-based venture was once valued at $6 billion and has collected DNA samples from more than 15 million customers. The company's bankruptcy has raised questions over privacy standards for genetic data, which experts say is uniquely sensitive, immutable and irreplaceable if stolen. Twenty-seven states and the District of Columbia filed the lawsuit, arguing that 23andMe customers have an inherent right to their own genetic information. 'This isn't just data — it's your DNA,' said Oregon Atty. Gen. Dan Rayfield in a statement. 'It's personal, permanent, and deeply private. People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest bidder.' 23andMe announced in May that it would be sold to New York-based drug maker Regeneron Pharmaceuticals, which had agreed to comply with 23andMe's existing privacy policy. However, a competing offer from nonprofit TTAM Research Institute led the bankruptcy judge to reopen the auction last week. TTAM is run by 23andMe co-founder Anne Wojcicki, who has made several failed attempts to take the company private. In a statement, a 23andMe spokesperson said the lawsuit's claims 'are without merit' and that the sale of genetic data does not violate privacy regulations. 'Customers will continue to have the same rights and protections in the hands of the winning bidder,' the spokesperson said. 23andMe customers have the right to delete their genetic information from the company's database at any time, as outlined in the Genetic Information Privacy Act and the California Consumer Privacy Act. During a testimony in Washington earlier this week, 23andMe interim Chief Executive Joseph Selsavage said that 1.9 million customers have requested their data be deleted since the company's bankruptcy filing in March. Sara Geoghegan, senior counsel at the Electronic Privacy Information Center, said that 23andMe's privacy policy was subject to change and not adequate to protect customers' data. In an interview in March, she stressed the sensitivity of genetic data. 'I would be very concerned if I had given a swab to 23andMe,' she said. 'There is little we can do to control what happens to it.'
Miami Herald
31 minutes ago
- Miami Herald
New lawsuit aims to halt sale of your data by DNA testing firm
23andMe was founded in 2006 and pioneered the direct-to-consumer genetic testing model. Customers responded positively, ordering DNA testing kits and submitting saliva swabs to find out about their ancestry and make connections with long-lost family members. With this success, at one point, the company's stock market valuation was close to $6 billion. Don't miss the move: Subscribe to TheStreet's free daily newsletter However, after going public and attempting to expand operations into new business lines including health care services and biotechnology, 23andMe ultimately filed for Chapter 11 bankruptcy protection on March 23, 2025. This did not mean the company discontinued operations, though, and in a Q&A document the company created about the filing, it explained that "your data remains protected. The Chapter 11 filing does not change how we store, manage, or protect customer data." Related: Major biotech company acquired after Chapter 11 bankruptcy Despite these assurances, many customers expressed concerns about the sensitive DNA information they'd submitted to 23andMe, prompting lawmakers to get involved. In a recent House Oversight Committee hearing, 23andMe's interim CEO Joseph Selsavage told lawmakers around 15% of the customer base, or 1.9 million people, had requested the deletion of their personal information, but this leaves a substantial amount of DNA data still under the control of the company. Now, 27 states have initiated a lawsuit that seeks to block the sale of this genetic information, raising questions about whether 23andMe has the right to sell DNA data without express consent. As 23andMe's bankruptcy proceedings have progressed, the plan was initially to sell the company to Regeneron, a biotech company, for $256 million, before 23andMe received an offer from TTAM Research Institute, a nonprofit newly launched by company Co-Founder Anne Wojcicki. The bankruptcy court reopened the auction to accept final bids from both potential buyers, but as this process played out, 27 states and D.C. filed suit to ask the bankruptcy court to consider whether selling the DNA data from more than 15 million customers is permissible without the express consent of customers. In court filing documents, the states assert that the transfer of this DNA data is not like an ordinary property sale in bankruptcy proceedings, and that special consideration is required. Related: Google resolves major privacy issue "23andMe holds - and is proposing to sell to a third party - an unprecedented compilation of highly sensitive and immutable personal data: a human being's permanent and everlasting genetic identity….the magnitude of the data in this proposed sale stretches far beyond the 23andMe consumers, impacting those who have no awareness of the sale as well as humans who no longer exist and do not exist yet," the court filings read. The states argue that the company can't just sell this customer information without first getting consent from each of the customers whose DNA data would be part of the transfer. A 23andMe company spokesperson said the AG's complaints "are without merit," adding that "customers will continue to have the same rights and protections in the hands of the winning bidder." For its part, Regeneron has acknowledged the sensitive nature of the information it would be purchasing, promising to process all of the customer data it receives in accordance with the 23andMe privacy policies that were in place before the sale. The company committed to complying with both applicable laws and the 23andMe terms of service and said it would put security controls in place to protect customer details. Related: OpenAI founder's newest project could destroy your privacy Still, this assurance was not enough to satisfy the states that are suing, and officials are speaking out to protect the rights of those whose information is at stake. "New Yorkers and many others around the country trusted 23andMe with their private information, and they have a right to know what will be done with their information. My office is joining 27 other attorneys general to protect people's most private information and to make sure 23andMe abides by the law," New York Attorney General Letitia James stated in a June 10 news release. More Tech News: Palantir gets great news from the PentagonAnalyst has blunt words on Trump's iPhone tariff plansOpenAI teams up with legendary Apple exec The bankruptcy court will need to consider the state's arguments before the information is handed over. The good news is that customers still have the opportunity to request closure of their account and deletion of their data, which the company explains can be done through the Account Settings option. Related: Veteran fund manager unveils eye-popping S&P 500 forecast The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
2 hours ago
- Yahoo
PA Attorney General joins lawsuit to stop 23andMe's sale of customer data
PENNSYLVANIA (WTAJ) — Following the filing of bankruptcy by 23andMe and their intent to potentially sell consumer data, PA Attorney General Dave Sunday announced on Wednesday, June 11, his office is joining a bipartisan group of 28 Attorney Generals from across the country to file a lawsuit to block the sale. 23andMe, a popular DNA testing company, filed for bankruptcy in March 2025 and is now looking to sell off its assets by auction. Those assets would include sensitive genetic and health data of its customers. 'The millions of consumers — including many Pennsylvanians — who paid for these services certainly did not expect their sensitive data to one day be sold off to a highest bidder,' Attorney General Sunday said. '23andMe is trying to avoid their legal obligations to consumers simply by labeling this sale and transfer of consumer data as a 'change of ownership.' I continue to encourage 23andMe customers to consider deleting their data from the company's database.' The lawsuit, filed in federal bankruptcy court on June 9, objects to the bankruptcy sale of the personal information that 23andMe collected and aims to stop the auctioning of it to the highest bidder. The argument is that this kind of information, such as biological samples, DNA data, and medical records, is too sensitive to be sold without every customer's consent and could potentially be used in ways that they were never informed of when they initially signed up for 23andMe. Pennsylvania joins attorneys general from states like Arizona, Florida, New York, and West Virginia in the lawsuit. Impacted consumers have until July 14, 2025, to file a proof of claim electronically and can submit a complaint to the Bureau of Consumer Protection or call the hotline at (800) 441-2555. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
